Study of Families With Twins or Siblings Discordant for Rheumatic Disorders
Pathogenic Studies In Families With Twins Or Siblings Discordant For Systemic Rheumatic Disorders
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Listed as NCT00055055, this observational or N/A phase trial focuses on Idiopathic Inflammatory Myopathies and Rheumatoid Arthritis and remains completed. Sponsored by National Institute of Environmental Health Sciences (NIEHS), it has been updated 81 times since 2003, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Study Description(click to expand)Most autoimmune diseases are thought to develop as a result of chronic immune activation and dysregulation after selected environmental exposures in genetically susceptible individuals. Current evidence suggests that the adult and juvenile forms of systemic rheumatic disorders -- defined here as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and idiopathic inflammatory myopathies (IIM) -- share many common clinical manifestations, immune responses, genetic, hormonal and environmental risk factors, and possible pathogeneses. Conversely, other studies imply that each rheumatic disease, as currently defined, may be composed of more homogeneous subgroups, known as elemental disorders, with different pathogeneses. This protocol will explore pathogenic mechanisms for systemic rheumatic disorders and possible elemental disorders through the evaluation of families with monozygotic or dizygotic twins or other siblings discordant for systemic rheumatic disorders (twin-sib pairs). Parents and healthy volunteers will also be evaluated as needed for the experimental designs of each portion of the protocol. A clinical evaluation, using standardized physician and patient clinical and environmental exposure questionnaires, and specimen collections from 400 twin-sib pairs discordant for systemic rheumatic disorders will be performed to confirm diagnoses, document medical histories and assess possible risk factors implicated in the development of autoimmunity. This study will...
Most autoimmune diseases are thought to develop as a result of chronic immune activation and dysregulation after selected environmental exposures in genetically susceptible individuals. Current evidence suggests that the adult and juvenile forms of systemic rheumatic disorders -- defined here as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), systemic sclerosis (SSc), and idiopathic inflammatory myopathies (IIM) -- share many common clinical manifestations, immune responses, genetic, hormonal and environmental risk factors, and possible pathogeneses. Conversely, other studies imply that each rheumatic disease, as currently defined, may be composed of more homogeneous subgroups, known as elemental disorders, with different pathogeneses. This protocol will explore pathogenic mechanisms for systemic rheumatic disorders and possible elemental disorders through the evaluation of families with monozygotic or dizygotic twins or other siblings discordant for systemic rheumatic disorders (twin-sib pairs). Parents and healthy volunteers will also be evaluated as needed for the experimental designs of each portion of the protocol. A clinical evaluation, using standardized physician and patient clinical and environmental exposure questionnaires, and specimen collections from 400 twin-sib pairs discordant for systemic rheumatic disorders will be performed to confirm diagnoses, document medical histories and assess possible risk factors implicated in the development of autoimmunity. This study will evaluate children, who will make up 25-50% of the twin-sib pairs, and adults in similar ways to attempt to understand possible similarities and differences in pathogeneses of systemic rheumatic disorders based upon age of onset. Hypothesis-testing studies will assess differences in peripheral blood cell gene activation/suppression, levels and types of microchimerism between affected and unaffected individuals, selected genetic risk factors for these disorders and occupational and hormonal exposures hypothesized to be potential risk factors for these diseases. Exploratory studies will be conducted to begin to assess other environmental risk factors for systemic rheumatic disorders and to better understand associations among phenotypes and genotypes. Biologic specimens -- including blood, urine, and other clinical specimens or biopsies no longer necessary for clinical care -- will be collected for directed biomarker assays and the development of repositories for future research.
Status Flow
Change History
81 versions recorded-
Apr 28, 2026 — Present [daily]
Completed
-
Apr 16, 2026 — Apr 28, 2026 [daily]
Completed
-
Feb 2026 — Apr 2026 [monthly]
Completed
-
Jan 2026 — Feb 2026 [monthly]
Completed
-
Dec 2025 — Jan 2026 [monthly]
Completed
▶ Show 76 earlier versions
-
Nov 2025 — Dec 2025 [monthly]
Completed
-
Oct 2025 — Nov 2025 [monthly]
Completed
-
Sep 2025 — Oct 2025 [monthly]
Completed
-
Aug 2025 — Sep 2025 [monthly]
Completed
-
Jul 2025 — Aug 2025 [monthly]
Completed
-
Jun 2025 — Jul 2025 [monthly]
Completed
-
May 2025 — Jun 2025 [monthly]
Completed
-
Apr 2025 — May 2025 [monthly]
Completed
-
Mar 2025 — Apr 2025 [monthly]
Completed
-
Feb 2025 — Mar 2025 [monthly]
Completed
-
Jan 2025 — Feb 2025 [monthly]
Completed
-
Dec 2024 — Jan 2025 [monthly]
Completed
-
Nov 2024 — Dec 2024 [monthly]
Completed
-
Oct 2024 — Nov 2024 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Jun 2024 — Jul 2024 [monthly]
Completed
-
May 2024 — Jun 2024 [monthly]
Completed
-
Apr 2024 — May 2024 [monthly]
Completed
-
Mar 2024 — Apr 2024 [monthly]
Completed
-
Feb 2024 — Mar 2024 [monthly]
Completed
-
Jan 2024 — Feb 2024 [monthly]
Completed
-
Dec 2023 — Jan 2024 [monthly]
Completed
-
Nov 2023 — Dec 2023 [monthly]
Completed
-
Oct 2023 — Nov 2023 [monthly]
Completed
-
Sep 2023 — Oct 2023 [monthly]
Completed
-
Aug 2023 — Sep 2023 [monthly]
Completed
-
Jul 2023 — Aug 2023 [monthly]
Completed
-
Jun 2023 — Jul 2023 [monthly]
Completed
-
May 2023 — Jun 2023 [monthly]
Completed
-
Apr 2023 — May 2023 [monthly]
Completed
-
Feb 2023 — Apr 2023 [monthly]
Completed
-
Jan 2023 — Feb 2023 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Nov 2022 — Dec 2022 [monthly]
Completed
-
Sep 2022 — Nov 2022 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Active Not Recruiting
-
May 2022 — Jun 2022 [monthly]
Active Not Recruiting
-
Apr 2022 — May 2022 [monthly]
Active Not Recruiting
-
Mar 2022 — Apr 2022 [monthly]
Active Not Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Active Not Recruiting
-
Jan 2022 — Feb 2022 [monthly]
Active Not Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Active Not Recruiting
-
Nov 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Active Not Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Apr 2021 — May 2021 [monthly]
Recruiting
-
Mar 2021 — Apr 2021 [monthly]
Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Recruiting
-
May 2020 — Jun 2020 [monthly]
Recruiting
-
Mar 2020 — May 2020 [monthly]
Recruiting
-
Feb 2020 — Mar 2020 [monthly]
Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Recruiting
-
Aug 2019 — Oct 2019 [monthly]
Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Recruiting
-
Jan 2019 — Jul 2019 [monthly]
Recruiting
-
Nov 2018 — Jan 2019 [monthly]
Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Apr 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
This study will examine families in which one sibling of a sibling pair, or twin pair, has developed a systemic rheumatic disease and one has not, to see if and how the two differ in the following: * Blood cell metabolism; * Types of cells in the blood; * Environmental exposures or genetic factors that might explain why one developed disease and the other did not. Families in which one sibling has developed a systemic rheumatic disease, rheumatoid arthritis, systemic lupus erythematosus, scleroderma, dermatomyositis, or myositis, and the other has not, are eligible for this study. The siblings may or may not be twins, but must be of the same gender and be within a 5-year age difference. Biological parents, or, in some cases, children, will also be included in the study. Normal, healthy volunteers will serve as control subjects. Participants will undergo some or all of the following tests and procedures: * Medical history and physical examination. Participants will also be asked permission to obtain medical records for review. * Questionnaires about environmental exposures at work, at home, and elsewhere. Probands (participants with rheumatic disease) and their healthy siblings will also answer questions about infections, vaccinations, medications or dietary supplements, sun exposure, and stressful events during the year before disease diagnosis in the affected sibling. * Blood and urine collection for the following tests: * Routine blood chemistries and other studies to rule out certain diseases or medical problems; * Evidence of past toxic exposures and certain infections; * Presence of cells from the mother in the child s blood and vice versa. (Recent studies suggest that during pregnancy or delivery, cells from the mother and baby may be exchanged and circulate in the body for many years, possibly causing problems); * In twin or sibling pairs, presence of certain genes that may be more common in patients with systematic rheumatic diseases as compared with their unaffected siblings and normal volunteers; * In identical twins, comparison of their blood cell metabolism to see if and how the metabolism differs in people with rheumatic disease. Participants may be asked for permission to have some of their blood and urine samples stored and to obtain previously collected blood or tissue biopsy specimens that are no longer needed for clinical care, for research purposes. They may also be asked to give additional blood or urine samples. Participants will be followed every year for 5 years (either in person or by questionnaire) to evaluate any changes in their condition. The final 5-year evaluation will repeat some of the questionnaires and procedures described above.
Contact Information
- National Institute of Environmental Health Sciences (NIEHS)
For direct contact, visit the study record on ClinicalTrials.gov .